Page 158 - CW E-Magazine (1-10-2024)
P. 158

News from Abroad


       MEDICINE PERSONALISATION
       Brenntag inks distribution deal with 3D printing

       firm, Craft Health


          Brenntag, the German chemical and                                            ingredients, including
       ingredients  distribution  firm,  has  an-                                      heat-sensitive materials
       nounced the appointment as distributor                                          and probiotics.
       for  Craft  Health,  Southeast  Asia’s  first                                   * Innovative product
       3D printing technology company offer-                                           design: The mould-free
       ing customised solutions for drug                                               production  technique
       delivery, with end-to-end solutions from                                        enables the creation
       research and development to manufac-                                            of complex and novel
       turing for the pharmaceuticals and                                              geometries in food and
       nutraceuticals industries.                                                      supplement  products,
                                                                                       opening new possi-
          Craft  Health’s 3D technology is                                             bilities for product
       enabling the creation of  personalised  tion and bring transformative solutions   innovation.
       tablets that can be customised in terms  to the healthcare industry,” said Dr. Wei  * Controlled release profiles: Custo-
       of shape, dosage, and active ingredient  Jiang Goh, CEO at Craft Health.  misable release profiles can
       delivery.                                                             be achieved, offering tailored
                                           According to the companies, 3D    solutions  for  specific  therapeutic
          “By  combining our  expertise and  printing technology for pharmaceutical   needs.
       optimising synergies in automating  and  nutraceutical applications  offers  * Rapid prototyping and low mini-
       mass customisation using our proprie-  several distinct advantages, including:  mum order quantities: The techno-
       tary  3D printing  systems  for pharma-  *  Versatility in active ingredients:   logy  allows for rapid prototyping
       ceuticals and nutraceuticals with    The 3D printing process is heat-free   of innovative formats with the
       Brenntag’s vast knowledge in chemical   and UV-free, performed at room   flexibility to produce low quanti-
       distribution and  quality products,  we   temperature and pressure, allowing   ties, catering to niche  markets
       aim to push the boundaries of innova-  the use of a wide range of active   and specialised patient needs.
       PROJECT PROGRESS
       LyondellBasell begins work on advanced recycling

       plant at German site


          Chemicals major,  LyondellBasell
       (LYB), laid the foundation of its first,
       catalytic advanced recycling plant at its
       Wesseling, Germany site in a ceremony
       attended by  German  Chancellor Olaf
       Scholz and Minister-President Hendrik
       Wüst.

          Targeted startup for the new unit is
       set for 2026, as part of the company’s
       strategy  to  build  a  profitable  Circular
       and Low Carbon Solutions business.

          Using LYB proprietary  MoReTec


       158                                                                    Chemical Weekly  October 1, 2024


                                      Contents    Index to Advertisers    Index to Products Advertised
   153   154   155   156   157   158   159   160   161   162   163